In comparison to cells from AD patients, upregulation of CCL18 mRNA expression was not regulated by these agonists (amthamine median 1.45-fold induction, 4-MH median 1.68-fold induction) Figure 7C,E). The gene discussed is CCL18; the disease is Alzheimer disease.